Featured Pharmacovigilance Experts

Imtiaz Ibne Alam, B.Pharm, RPh, is a registered pharmacist and freelance medical writer with 15+ years of experience across healthcare, pharmaceutical writing and scientific communication. He writes and edits peer-reviewed manuscripts, systematic reviews, pharmacovigilance and drug safety documents, regulatory and CMC content and patient education on topics such as diabetes and glucose monitoring. He has supported 20+ indexed publications and is a named co-author in the Journal of Integrative Medicine. He is available to comment on medical writing, publication ethics, drug safety, evidence-based health content and the responsible use of AI in medical writing.

I'm a pharmacist and healthcare professional with more than 20 years of experience across pharmaceutical inspection, healthcare quality management, occupational health and safety, and clinical pharmacy. I earned my Bachelor of Pharmacy in 2005 and began my career in pharmaceutical inspection, working with pharmaceutical regulations, quality standards, and medication compliance. This experience gave me a strong understanding of healthcare quality and safety and shaped my commitment to improving patient and public health outcomes. I later moved into healthcare quality management, where I worked on quality improvement, patient safety, accreditation, and risk management. Today, I work in Occupational Health and Safety Management, helping organizations create safer workplaces while promoting employee health and wellbeing. I'm also in the final year of a Professional Master's degree in Clinical Pharmacy, continuing to develop my knowledge of pharmacotherapy, evidence-based medicine, and clinical decision-making. Over the years, I've developed a particular interest in making complex healthcare information easier to understand and apply in everyday life. I believe good health communication should be accurate, practical, evidence-informed, and free from unnecessary medical jargon. I'm also the founder of LULIQUA, a UK-registered wellness company focused on evidence-informed approaches to pain relief, recovery, and everyday self-care. This work has strengthened my interest in consumer wellness, product evaluation, and responsible health communication. My areas of expertise include pain management, heat therapy, musculoskeletal health, workplace wellness, occupational health and safety, healthcare quality, patient safety, medication safety, preventive healthcare, clinical pharmacy, and evidence-based wellness. I'm happy to provide clear, evidence-informed commentary for journalists, editors, and content creators covering healthcare, wellness, workplace health, and related topics. For expert commentary or media enquiries: 📧 ghada@luliqua.com

Michael Guirguis is a Harvard-trained emergency medicine physician and the world's leading expert in protective medicine for the executive protection industry. With 22 years in emergency medicine, a law enforcement background, and a current license as an executive protection agent, he's the rare practitioner operating at the security-medicine crossover with real field credentials. He founded Raven Medical Support Group to solve a specific problem: most protective medicine programs fail because the medical side is either underskilled, undertrained, or completely inaccessible. His benchmark is the Chipotle Vegas conference — a 5,000-person event where he built the medical program from scratch, staffed it with contracted paramedics, protected C-suite executives, and treated four guests for acute medical issues, all without theater. Michael serves as Medical Director for Chipotle Global Protective Services and UHNW family offices. His deliverables include SOPs, Scope of Practice documents, principal-specific medical kit specifications, training programs, and event medical staffing. Every program he builds is legally defensible, scope-appropriate, and tailored to the people being protected. He's never just a name on paper — he's accessible, he's hands-on, and he's the one making the calls when something goes wrong. He's spent two decades calling out the gaps in his industry: the conflation of EMTs and Paramedics (they're not interchangeable), the misuse of tactical trauma courses as a substitute for real medical training (most emergencies are medical, not trauma), and the proliferation of "paper medical directors" who exist only for compliance. His conviction is simple: good protective medicine requires genuine competence, real accessibility, and gear tailored to the principals being protected. Michael is a regular contributor on LinkedIn, where he shares field insights on protective medicine governance, team training, and the realities of high-net-worth security operations. He's registered with Medfluencers for brand partnership opportunities and speaks to CSOs, EP managers, and security teams on the integration of medical expertise into protective programs.

Dr. Manthan Tripathi is a medical professional, healthcare writer, and digital health educator based in India, with a clinical foundation from Atal Bihari Vajpayee Medical University, Lucknow. He combines frontline medical training with over 3,000 published articles across patient education, preventive medicine, medical technology, and AI in healthcare, making him one of India's most prolific evidence-based health communicators. His work has appeared on platforms including Medicircle, HospitalSuggest, HealthVoice, DocVo, Dr. Malpani and IVF Matters, and is recognized for translating complex clinical concepts into accurate, reader-friendly content that helps patients make genuinely informed decisions. His healthcare and education content has generated over 55 million cumulative views across digital platforms. Dr. Tripathi brings a perspective that is rare among health sources: deep India-specific clinical knowledge, including India's disease burden, government health schemes, Indian drug brand names, and regional dietary patterns; context that generic Western health content consistently misses. He is the founder of drmanthan.com, an evidence-based health information and clinical tools platform built specifically for Indian patients, families, and medical students. He has also worked as a Subject Matter Expert with Physics Wallah and Chegg India, contributing academic content for competitive medical examinations including NEET. His areas of expertise include internal medicine, thyroid and metabolic disorders, diabetes, preventive health, and India-specific patient education. Journalists covering Indian healthcare, global health disparities, patient literacy, medical misinformation, or AI in medicine will find in Dr. Tripathi a source who speaks with both clinical accuracy and genuine public communication experience.

Saad Shakir is one of the leading experts in Europe in pharmacoepidemiology, pharmacovigilance, risk management and risk minimisation in pharmacovigilance. He leads a team who conduct studies in these fields. He advises widely on matters related to these areas. Saad chairs and sits on advisory committees and Data Safety Monitoring Boards.

Dr. Akshaya Srikanth Bhagavathula is an Associate Professor of Epidemiology at North Dakota State University, internationally recognized for his pioneering work at the intersection of digital epidemiology, pharmacovigilance, and artificial intelligence. His research harnesses advanced statistical modeling and AI to track and predict health behaviors, medication safety, and disease patterns in real time—bridging traditional epidemiology with next-generation digital health analytics. Dr. Bhagavathula has published more than 250 peer-reviewed articles in leading journals, including Annals of Epidemiology, JAMA Network Open, and Lancet Digital Health. His work has been widely cited and featured in major media outlets such as The New York Times, where he discussed the real-world safety of GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy, Mounjaro). Recognized among the Stanford–Elsevier Top 2% of Scientists (2019–2024) and elected as a Fellow of the American College of Epidemiology, Dr. Bhagavathula is known for translating complex data into actionable insights that shape public health policy and clinical practice. His ongoing projects include NIH- and NSF-aligned initiatives on AI-powered overdose forecasting, digital twins for public health, and real-world drug safety surveillance using explainable machine learning. With a decade of experience spanning more than two dozen countries and collaborations with organizations such as WHO, USAID, and UNICEF, Dr. Bhagavathula brings a global, data-driven, and human-centered approach to solving modern health crises.

I am a practicing clinical pharmacist with over 20 years of experience and a graduate of St. John’s University School of Pharmacy in Queens, NY. With an undergraduate background in compounding and natural medicine, I have served in various capacities across the pharmaceutical industry before founding Fusion Medical Care in Scottsdale, AZ. My career is defined by my dedication to a balanced approach between natural and allopathic medicine, a passion that led me to develop a complete wellness center housing multiple integrative practitioners. Beyond my foundational education, I have advanced my specialized training through the Professional Compounding Centers of America and am a Certified Diplomate of the American Board of Anti-Aging Health Practitioners. I believe that my role as a pharmacist offers the perfect opportunity to fuse naturopathic and allopathic care, acting as a dedicated advocate for my patients' pharmacological and wellness needs. My mission is to empower patients to look and feel amazing by following my core philosophy: "Let your food be your medicine, your kitchen be your pharmacy, and your lifestyle be your doctor". My innovative approach to healthcare has earned me national recognition, including an honor in Marquis Who’s Who and a featured interview with VoyagePhoenix highlighting my journey and the mission behind Fusion Medical Care.

In my role, I meticulously oversee various clinical projects, ensuring each phase is executed with precision and in compliance with GCP standards. Core Competencies: Clinical Trials Monitoring Clinical Safety Protocols Streamlined Clinical Operations Regulatory Compliance Mastery Educational Background: MSc in Molecular Science and Nanotechnology, Louisiana Tech University MSc in Medical Genetics, MGM University of Health Sciences With a robust educational foundation and a keen eye for detail, I have successfully navigated through different therapeutic areas and regions, delivering high-quality results consistently. My journey in the realm of clinical research is driven by an insatiable curiosity and a deep-seated commitment to advancing science and practice. Let’s Connect! If you are passionate about transforming health care and improving patient lives, or if you wish to exchange insights and collaborate on projects, feel free to connect with me. Together, let’s contribute to a healthier, more understanding world for individuals navigating through challenges.

Shane Hellmrich holds a BSc in Health Promotion and has spent the past 11 years independently testing and reviewing online modafinil vendors — placing personal test orders, verifying product authenticity, and documenting shipping reliability across dozens of suppliers. His work at BuyModa.net tracks over 1,300 verified customer transactions and maintains a public testing methodology that has become a trusted reference point for consumers navigating the grey-market pharmaceutical space. Shane's research covers vendor reliability scoring, product authentication, shipping logistics across international jurisdictions, and the pharmacokinetic profiles of generic modafinil products. He is regularly consulted on topics including nootropics and cognitive enhancement, online pharmacy safety and regulation, pharmaceutical sourcing and supply chain transparency, consumer protection in unregulated markets, and the real-world usage patterns of prescription cognitive enhancers. Shane is available for expert commentary, background briefings, and on-the-record quotes for journalists covering health, productivity, pharmacology, biohacking, and consumer safety.

Dr. Jagdish Khubchandani is a Professor of Public Health at New Mexico State University (NMSU), known for his extensive research and expertise in global health and social epidemiology

I’m a lifesciences compliance strategist with a passion for building real-world, right-sized programs in fast-moving environments. With deep experience in pharma and medtech, I specialize in translating regulatory complexity into practical, actionable frameworks. I’ve spent 7+ years navigating the gray areas of compliance—from training physicians on industry expectations to building startup programs from the ground up. I believe compliance should be ethical, functional, and human-centered—and that culture is built through clarity, storytelling, and respect, not fear. Outside of policy and audits, I speak regularly on startup compliance and love turning “boring” topics into memorable moments. I'm here to connect, create, and contribute.

I edit Europe Pharma Today — a Europe-first news desk covering EMA and CHMP decisions, EU HTA, and national market-access moves for industry professionals. We focus on what changed, what it means for access, and what to watch next — with clear sourcing, not noise.

Emanuele Andreano is an immunologist and biotech innovator redefining how vaccines are discovered for pandemic threats. As Head of Serology and Immunology at the Fondazione Biotecnopolo di Siena and a leader in the European Vaccine Hub, he works at the intersection of AI, immunology, and global health. He pioneered Reverse Vaccinology 3.0, a breakthrough approach that can identify entirely new vaccine targets in days instead of years. In a first-of-its-kind demonstration, his team showed that artificial intelligence can predict unknown viral antigens directly from human antibody sequences—effectively reversing the traditional vaccine discovery process. His work spans monoclonal antibody discovery and next-generation vaccines against emerging pathogens, including mpox and SARS-CoV-2, with direct implications for global pandemic preparedness and biosecurity. Andreano has received international recognition, including the Antonio Feltrinelli Prize from the Accademia Nazionale dei Lincei, awarded in the presence of the President of the Italian Republic Sergio Mattarella, the IUIS Rising Star in Immunology, and a European Research Council (ERC) grant. He also co-directs a vaccinology program at the Institut Pasteur in Paris. “We are entering an era where vaccines can be discovered at unprecedented speed—transforming our ability to fight pandemics and save countless lives.”

Dr. Sarassawadee Suwanjinda ("Dr. Petch") is Co-Founder and Chief Medical Strategy Officer at Healthi Life, Bangkok's Urban Longevity House. Certifications: - International Board of Lifestyle Medicine (IBLM) - International Society for Stem Cell Application (ISSCA) - Certified Board of Anti-Aging Medicine (CBAM) - American Academy of Aesthetic Medicine (AAAM) - Certificate in Aesthetic Medicine 10+ years of clinical experience in longevity, regenerative, functional, and lifestyle medicine. Available for expert medical commentary on: - Longevity medicine and healthspan extension - Stem cell and exosome therapy safety - NAD+ IV therapy and mitochondrial health - Peptide therapy and physician oversight (Tirzepatide, Retatrutide, BPC-157) - Hormone optimization (testosterone, perimenopause) - 300+ biomarker health check-ups - Functional medicine for chronic conditions Located in Ekkamai, Bangkok. Serving 50+ nationalities.

Vardan Ter-Antonyan is a scientist, operator, author, entrepreneur, and executive who has spent more than two decades inside pharmaceutical and regulated environments, advancing from technical roles into senior leadership and C-suite responsibility. His experience spans organizations ranging from early-stage ventures to large-scale enterprises with thousands of employees. Having worked at the intersection of science, operations, and executive governance, Vardan has observed firsthand how leadership decisions are actually made, particularly the often-unspoken criteria organizations use when selecting executives. C-Suite Bible reflects those observations, informed by both his own tenure in senior roles and his exposure to CXO transitions. In addition to his corporate leadership experience, Vardan has founded and advised businesses, further deepening his perspective on risk, capital allocation, and institutional trust. He holds a Master’s degree in Molecular Biophysics, is a Lean Six Sigma Master Black Belt, and is pursuing a Doctor of Business Administration degree. Throughout his career, Vardan has led multidisciplinary R&D teams, developed novel drug delivery systems, optimized manufacturing processes, and helped organizations bring innovative products to market while navigating complex regulatory requirements. His technical expertise includes lipid-based drug delivery systems, nanoemulsions, self-emulsifying drug delivery systems (SEDDS/SNEDDS), liposomes, controlled-release technologies, and formulation development for poorly water-soluble compounds. In addition to his scientific leadership, Vardan is passionate about bridging the gap between research and commercial success. He regularly advises companies on product development strategy, technology commercialization, operational excellence, and innovation management. His work combines deep scientific knowledge with practical business insight, enabling organizations to accelerate development timelines, improve product quality, and reduce technical risk. Vardan is also an author, speaker, and industry thought leader who enjoys sharing evidence-based perspectives on pharmaceutical innovation, drug delivery, biotechnology, diagnostics, manufacturing, and executive leadership. He welcomes opportunities to provide expert commentary for journalists covering advances in pharmaceutical science, healthcare innovation, biotechnology, regulatory affairs, and emerging medical technologies.

I'm a Pharm.B student with a background in pharmacology and biochemistry, and the founder of NakedCompound.in — a research-backed supplement review platform built for Indian buyers. I specialize in analyzing clinical evidence behind supplement ingredients, evaluating label accuracy, identifying underdosed or adulterated products, and translating complex pharmacology into practical guidance for everyday consumers. My work covers protein supplements, creatine, ashwagandha, BCAAs, pre-workouts, and other sports nutrition compounds — with specific context around FSSAI regulations, Indian brand quality standards, and bioavailability in Indian dietary patterns. I'm available to comment on supplement science, sports nutrition, nutraceutical safety, ingredient interactions, and the Indian wellness market.

Dr. Teralyn Sell, PhD, LPC is a licensed psychotherapist and nationally recognized authority on psychology-led, biology-informed psychiatric medication decision-making. Her work focuses on antidepressant withdrawal, informed consent, therapist clinical judgment under uncertainty, and the long-term psychological and physiological consequences of misinterpreting medication effects. With more than 20 years in mental health, Dr. Sell is known for clarifying the difference between relapse and withdrawal, examining how fear and risk aversion shape treatment decisions, and explaining why many patients struggle when exiting psychiatric medications. Her perspective bridges psychotherapy, neurobiology, and real-world clinical practice, offering a nuanced alternative to oversimplified mental health narratives. Dr. Sell has been featured across national and regional media, including television appearances, radio interviews, podcasts, and print and digital publications, where she provides expert commentary on mental health reform, medication safety, and whole-person care. She is the co-host of The Gaslit Truth Podcast, a widely followed show examining gaps in psychiatric narratives and the lived realities of patients navigating medication use and withdrawal. She is frequently sought out by journalists for her ability to translate complex clinical and research issues into clear, grounded insights without alarmism, ideology, or prescriptive messaging, helping audiences better understand risk, trade-offs, and long-term outcomes in mental health care. Areas of Expertise Antidepressant withdrawal and discontinuation Mental health informed consent Therapist formulation and clinical judgment Psychiatry and psychotherapy system gaps Medication risk communication Mind–body mental health Patient trust and treatment credibility

I am an MD-PhD physician-scientist with a passion for translating complex clinical and scientific data into clear, accurate content. My training and experience span clinical practice and translational research, with expertise across oncology, immunology, gastroenterology, inflammation & metabolism, and rare diseases. With over 10 years of experience, I have supported key deliverables including more than 30 peer-reviewed publications, manuscripts, slide decks, literature reviews, and scientific narratives. I enjoy working in collaborative, deadline-driven environments and am particularly interested in medical writing, medical information, and publication development, where scientific accuracy and effective storytelling intersect.

Aldo Vidinha is an internationally experienced leader with more than 18 years of expertise in the pharmaceutical industry, specializing in Engineering, Validation & Qualification, GMP Compliance, Quality Assurance, and Manufacturing. Throughout his career, he has successfully led and delivered the construction, start-up, commissioning, qualification, and validation of multiple pharmaceutical manufacturing facilities across Europe, the USA, Australia, and China. As a Project Lead, Aldo has managed capital expenditure projects valued at up to €18 million for major international pharmaceutical players. His proven track record demonstrates his ability to navigate complex technical and regulatory challenges while delivering projects on time and to the highest quality standards. Beyond his technical expertise, Aldo is a highly driven and motivated leader known for his strategic thinking and ability to build high-performance teams. He brings a unique combination of deep industry knowledge and strong business acumen, enabling him to contribute at both executive and governance levels. His areas of professional interest include engineering innovation, sustainability, Industry 4.0 and 5.0, and the advancement of pharmaceutical validation and qualification practices. With a passion for shaping the future of pharmaceutical engineering, Aldo continues to make a significant impact on the industry through leadership, thought partnership, and consulting.

Darrion Phelps, Sr. leads with a rare blend of strategy and street-level insight. As Chief Marketing Officer of Roxford Digital, he’s built a model that bridges the gap between online visibility and local credibility. His approach aligns marketing with business development — two sides of the same growth engine. Through marketing, his team strengthens a brand’s online presence, optimizing search, content, and communication so patients can find, trust, and select a preferred provider. Through business development, he mobilizes Brand Growth Partners — professionals who serve as local ambassadors developing referral relationships, building community awareness, and turning trust into measurable growth. It’s a system designed to make healthcare brands seen online and chosen in person — blending modern marketing precision with relationship-driven connections.